| Literature DB >> 34294048 |
Daniela Longo1, Laura Papetti2, Alessia Guarnera1,3, Francesca Bottino4, Antonio Napolitano5, Giorgia Sforza2, Marco Cappa6, Laura Chioma6, Luca Pasquini3,7, Maria Camilla Rossi-Espagnet1,3, Giulia Lucignani1, Lorenzo Figà-Talamanca1, Chiara Carducci1, Claudia Ruscitto8, Massimiliano Valeriani2,9.
Abstract
BACKGROUND: Migraine is the most common neurological disease, with high social-economical burden. Although there is growing evidence of brain structural and functional abnormalities in patients with migraine, few studies have been conducted on children and no studies investigating cortical gyrification have been conducted on pediatric patients affected by migraine without aura.Entities:
Keywords: aura; cortical abnormalities; cortical morphometry; cortical thickness; local gyrification index; magnetic resonance imaging; migraine; pediatric; phonophobia
Mesh:
Year: 2021 PMID: 34294048 PMCID: PMC8296718 DOI: 10.1186/s10194-021-01290-y
Source DB: PubMed Journal: J Headache Pain ISSN: 1129-2369 Impact factor: 7.277
Statistical analysis performed on Cortical Thickness and Local Gyrification Index
| PATIENTS VS CONTROLS | |||
|---|---|---|---|
| Patients | 72 | Controls | 82 |
| Patients < 12 y | 42 | Controls < 12 y | 46 |
| Patients ≥ 12y | 30 | Controls ≥ 12y | 36 |
| < 12y | 46 | ≥ 12y | 36 |
| Females | 41 | Males | 41 |
| Patients < 12y | 42 | ≥ 12y | 30 |
| Females | 42 | Males | 30 |
| Patients with MMD < 5 | 42 | Patients with MMD ≥ 5 | 30 |
| Patients with photophobia and phonophobia | 41 | Patients with photophobia or phonophobia | 62 |
| Patients with photophobia | 50 | Patients without photophobia | 22 |
| Patients with nausea and/or vomiting | 38 | Patients without nausea and/or vomiting | 34 |
The table illustrates the statistical analysis performed separately on cortical thickness and gyrification between: healthy patients and patients; subgroups of healthy controls and subgroups of patients. Cohort 1 and cohort 2 indicate the two groups of patients compared for each statistical analysis and n° indicates the number of patients forming a particular cohort.
MMD: migraine monthly days.
Main demographic and clinical characteristics of healthy controls and patients affected by migraine without aura. Neither gender distribution (P = 0.2) nor mean age (P = 0.2) significantly differed between patients with migraine and healthy control subjects
| Characteristics | Healthy Controls | Patients |
|---|---|---|
| N° of Subjects | 82 | 72 |
| N° of Subjects < 12 years | 46 | 42 |
| N° of Subjects ≥ 12 years | 36 | 30 |
| N° F/M | 41/41 | 42/30 |
| Mean Age in years (STD) | 10.96 (3.75) | 11.73 (3.19) |
| N° of Subjects presenting MMG < 5 | - | 42 |
| N° of Subjects presenting MMG ≥ 5 | - | 30 |
Migraine Duration per attack in hours (N° of patients) | - | < 2 h (26), <4 h (27), < 72 h (19) |
| Months since first attack (n° of patients) | - | < 6 (3), < 12 (12), < 24 (13), < 36 (19), < 72 (25) |
| Pain Intensity | - | mild (20), moderate (22), severe (30) |
| N° of Subjects presenting Photophobia | - | 50 |
| N° of Subjects presenting Phonophobia | - | 53 |
| N° of Subjects presenting Nausea | - | 35 |
| N° of Subjects presenting Vomiting | - | 16 |
| N° of Subjects presenting familiar cases of migraine | - | None (9), Mother (35), Father (7), Both parents (21) |
F/M: females/males; STD: standard deviation; MMD: migraine monthly days.
Results obtained from the statistical analysis performed on Cortical Thickness and Local Gyrification Index
| LOCAL GYRIFICATION INDEX | |||||
|---|---|---|---|---|---|
| 1262 | 0.01 | 3.53 (2.40) | 3.51 (2.33) | ||
| 1014 | 0.01 | 3.68 (2.57) | 3.65 (2.52) | ||
| 256 | 0.02 | 4.03 (2.74) | 4.00 (2.66) | ||
| 187 | 0.05 | 3.40 (1.81) | 3.49 (1.88) | ||
| 888 | 0.05 | 3.25 (1.79) | 3.30 (1.87) | ||
| 724 | 0.04 | 3.41 (2.09) | 3.47 (2.17) | ||
| 111 | 0.05 | 3.95 (2.67) | 4.04 (2.75) | ||
| 405 | 0.04 | 3.30 (2.01) | 3.37 (2.09) | ||
| 356 | 0.02 | 2.43 (0.98) | 2.36 (0.96) | ||
| 434 | 0.02 | 2.78 (0.67) | 2.71 (0.65) | ||
| 3914 | 0.02 | 2.74 (0.73) | 2.67 (0.71) | ||
| 705 | 0.02 | 2.67 (0.74) | 2.61 (0.72) | ||
| 1186 | 0.02 | 2.61 (0.85) | 2.54 (0.83) | ||
| 739 | 0.03 | 2.73 (0.74) | 2.65 (0.72) | ||
| 427 | 0.03 | 2.66 (0.78) | 2.58 (0.76) | ||
| 523 | 0.03 | 2.71 (0.80) | 2.64 (0.79) | ||
| 361 | 0.03 | 2.64 (0.74) | 2.56 (0.72) | ||
| 113 | 0.04 | 2.52 (0.94) | 2.48 (0.92) | ||
The table illustrates the results from statistical analysis performed separately on cortical thickness and gyrification between: healthy patients and patients; subgroups of healthy controls and subgroups of patients.
LGI: local gyrification index; CT: cortical thickness; mm: millimetres.
Fig. 1The figure shows differences in local gyrification index in patients compared to healthy controls (A) and in female patients compared to male patients (B). In a, regions of decreased local gyrification index in patients vs. controls are shown through a color scale ranging from yellow (p < 0.05) to red (p < 0.01). In b, regions of decreased local gyrification index in females vs. males are shown through a color scale ranging from yellow (p < 0.05) to red (p < 0.03). Only the most representative views are shown.
Fig. 2The figure shows differences in cortical thickness in ≥ 12-year-old patients compared to < 12-year-old patients (A) and in patients with nausea and/or vomiting compared to patients without nausea and/or vomiting (B). In a, regions of decreased cortical thickness in ≥ 12-year-old patients vs. < 12-year-old patients are shown through a colour scale ranging from yellow (p < 0.05) to red (p < 0.007). In b, regions of increased cortical thickness in patients with nausea and/or vomiting vs. patients without nausea and/or vomiting are shown through a colour scale ranging from yellow (p < 0.05) to red (p < 0.007). Only the most representative views are shown.